solriamfetol Inhibitor

Name: solriamfetol Inhibitor; MyBioSource
Brand: MyBioSource
SKU: MBS5758475
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758475

Solriamfetol is a new selective dopamine and norepinephrine reuptake inhibitor with robust wake-promoting effects. More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Product Name

solriamfetol, Inhibitor

Full Product Name

solriamfetol

Form/Format

Solid. Powder

Purity/Purification

98.00%

Preparation and Storage

Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent

Molecular Weight

194.23

Solubility

DMSO: 250mg/mL (1287.13mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)

Boiling Point

398.57 degree C (rough estimate)

Formula

C10H14N2O2

SMILES

NC(=O)OC[C@H](N)Cc1ccccc1

CAS Number

178429-62-4

Target & IC50

dopamine transporter: ic50 2.9uM
norepinephrine transporter: ic50 4.4uM
norepinephrine transporter (NET)
dopamine transporter

Product Categories/Family for solriamfetol, inhibitor

Neuroscience; GPCR/G Protein

Product References and Citations for solriamfetol, inhibitor

Baladi M G, Forster M J, Gatch M B, et al. Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor[J]. Journal of Pharmacology and Experimental Therapeutics, 2018:jpet.118.248120-.
Baladi M G, Forster M J, Gatch M B, et al. Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor[J]. Journal of Pharmacology and Experimental Therapeutics, 2018:jpet.118.248120-.
Abad V C, Guilleminault C. Solriamfetol for the treatment,of daytime sleepiness in obstructive sleep apnea[J]. Expert Review of Respiratory Medicine, 2018.
Abad V C, Guilleminault C. Solriamfetol for the treatment,of daytime sleepiness in obstructive sleep apnea[J]. Expert Review of Respiratory Medicine, 2018.

Other Notes

Small volumes of solriamfetol, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for solriamfetol purchase

MBS5758475 is an inhibitor targeting solriamfetol.